These equity awards fall under GRAIL’s Inducement Equity Incentive Plan, adhering to Nasdaq Listing Rule 5635(c)(4). The company reserves this specific mechanism exclusively for incoming staff who have not previously held roles within the organization, ensuring the grants function strictly as a recruitment incentive.
In section Releases
GRAIL Issues Inducement Equity Grants to New Hires
To secure its latest cohort of non-executive talent, Sunnyvale-based GRAIL, Inc. has issued restricted stock units covering 55,867 shares of common stock. The grants, awarded to 59 new employees, serve as a material inducement for their recent commitment to the healthcare company’s early-stage cancer detection mission.
The restricted stock units follow a standard four-year vesting schedule. Initial vesting of 25% is set for August 31, 2027, with subsequent portions released on each annual anniversary thereafter. Retention of these shares remains contingent upon the recipients maintaining active employment with the company or its subsidiaries throughout the four-year term.
Comments (0)
No comments yet. Be the first!